Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/20095
Title: Selective loss of levator ani and leg muscle volumes in men undergoing androgen deprivation therapy.
Authors: Cheung, Ada S;Cunningham, Christopher;Ko, Dong-Kyoon Daniel;Ly, Vivian;Gray, Hans;Hoermann, Rudolf;Strauss, Boyd J G;Hassan, Ebrahim Bani;Duque, Gustavo;Ebeling, Peter;Pandy, Marcus G;Zajac, Jeffrey D;Grossmann, Mathis
Affiliation: Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom
Department of Mechanical Engineering, The University of Melbourne, Parkville, Victoria, Australia
Department of Medicine - Western Precinct and Australian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne, St Albans, Victoria, Australia
Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
Department of Endocrinology, Austin Health, Heidelberg, Victoria, Australia
Department of Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia
Issue Date: 31-Dec-2018
EDate: 2018-12-31
Citation: The Journal of clinical endocrinology and metabolism 2018; online first: 31 December
Abstract: Androgen deprivation therapy (ADT) for prostate cancer (PCa) leads to a selective loss of leg muscle function during walking. Rodent models of ADT demonstrate that levator ani is exquisitely androgen sensitive. To determine whether the high androgen responsiveness of the levator ani muscle documented in rodents is evolutionarily conserved, and ADT is associated with a selective loss in leg muscle volumes. Prospective longitudinal case-control study. Tertiary referral hospital. 34 men newly commencing ADT and 29 age-matched PCa controls. Muscle volumes (litres) of levator ani, and of primary muscles involved in walking (iliopsoas, quadriceps, gluteus maximus, gluteus medius, calf). Compared to controls over 12 months, men receiving ADT had a mean reduction in total testosterone from 14.1 to 0.4nmol/L and demonstrated greater decreases in levator ani (MAD -0.005litres [-0.007, -0.002], p=0.002, -16% of initial median value), gluteus maximus (MAD -0.032litres [-0.063, -0.002], p=0.017, -5%), iliopsoas (MAD -0.005litres [-0.001, 0.000], p=0.013, -5%) and quadriceps (MAD -0.050litres [-0.088, -0.012], p = 0.031, -3%). No significant differences were observed in gluteus medius and calf muscles. Androgen responsiveness of levator ani appears to be evolutionarily conserved in humans. ADT selectively decreases volume of muscles that support body weight. Interventional strategies to reduce ADT-related sarcopenia and sexual dysfunction should assess whether targeting these muscle groups, including the pelvic floor improves clinical outcomes.
URI: http://ahro.austin.org.au/austinjspui/handle/1/20095
DOI: 10.1210/jc.2018-01954
PubMed URL: 30602021
Type: Journal Article
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.